<DOC>
	<DOC>NCT00671814</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of single rising oral doses and multiple oral doses of TR-701</brief_summary>
	<brief_title>Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy Adults</brief_title>
	<detailed_description>This is an evaluation of TR-701 in a double-blind, placebo-controlled, randomized, single (Part A) and multiple (Part B) ascending dose safety, tolerance, and PK when administered as a capsule in normal, healthy adult volunteers. The study will be sequential between Part A and Part B (i.e., not staggered or leap frogged), with slight overlap between last cohort in Part A and first cohort in Part B.</detailed_description>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Torezolid phosphate</mesh_term>
	<criteria>in good health body mass index of 20 to 29.9 kg/m2 female subjects must be either postmenopausal for at least 1 year, surgically sterile, abstinent, or agree to use an effective method of birth control history or clinical manifestations of any clinically significant disorder history of hypersensitivity or allergies to any drug compound history of stomach or intestinal surgery or resection history of alcoholism or drug addiction within 1 year use of any tobaccocontaining or nicotinecontaining products within 6 months use of any other medications use of alcoholcontaining, grapefruitcontaining, or caffeinecontaining foods or beverages; or foods or beverages with high levels of tyramine pregnancy, lactation, or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>antibiotic</keyword>
</DOC>